CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB-IIIA NSCLC
CANOPY-N:一项评估卡那单抗或帕博利珠单抗单药或联合用药作为新辅助治疗可切除的IB-IIIA期非小细胞肺癌患者的II期研究
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2025.100859
Lee, Jay M; Pujol, Jean-Louis; Zhang, Jun; Leonov, Oleg; Tsuboi, Masahiro; Kim, Edward S; Ng, Calvin; Moreno-Mata, Nicolas; Cummings, Amy; Hacibekiroglu, Ilhan; Sehitogullari, Abidin; Veeramachaneni, Nirmal; Spillane, Cathy; Duan, Jiawei; Bossen, Claudia; Savchenko, Alexander; Lobetti-Bodoni, Chiara; Mok, Tony; Garrido, Pilar